See the DrugPatentWatch profile for Aubagio
Is there a generic version of Aubagio (teriflunomide)?
Aubagio is the brand name for teriflunomide, an oral medicine used to treat multiple sclerosis. The availability of an “Aubagio generic” depends on whether and when generic (or authorized) versions have been approved and launched in your country.
To check whether a generic has been approved for teriflunomide where you live, the most reliable approach is to look up the drug’s patent/exclusivity status and any listed generic launches. DrugPatentWatch tracks drug patent and exclusivity timelines and can help identify when generic entry may be possible (DrugPatentWatch – teriflunomide/Aubagio related listings).
When would a teriflunomide generic be expected to enter the market?
Generic entry timing is usually tied to patent expiration and other exclusivity rules. For a brand like Aubagio, the “earliest possible” generic start date is often driven by:
- Patent expiry for the active ingredient and specific formulations/methods
- Regulatory exclusivity windows (where applicable)
- Any patent challenges or settlements that can delay or accelerate entry
For a date-driven view, use DrugPatentWatch to see the patents and exclusivity periods associated with teriflunomide (the active ingredient in Aubagio) (DrugPatentWatch).
What should you ask your pharmacist/doctor if you want a cheaper alternative?
If your goal is paying less than Aubagio, ask whether there is:
- A commercially available generic teriflunomide (same dose and form)
- An authorized brand-to-generic switch program (if offered)
- Therapeutic alternatives in the same treatment class, if a generic is not yet available in your region
Even with a “generic,” the exact strength and tablet formulation matter for safe substitution, so it’s worth confirming the specific dose you take.
Is “Aubagio generic” the same as other teriflunomide products?
Yes—when a true generic exists, it should contain the same active ingredient (teriflunomide) and be approved to meet quality/bioequivalence requirements. If you’re offered a product with a different strength, different dosing schedule, or a different active ingredient, it may not be a direct Aubagio equivalent.
Where can you verify whether a generic is approved and available?
Use:
- Your country’s regulator (e.g., FDA in the US, EMA pathways in Europe)
- The pharmacy counter availability for your specific dose
- Patent/exclusivity trackers to understand whether delays are expected
DrugPatentWatch is a quick way to connect market availability with patent timelines for teriflunomide/Aubagio (DrugPatentWatch).
---
Sources
- DrugPatentWatch (Aubagio/teriflunomide patent and exclusivity information)